Skip to main content
Premium Trial:

Request an Annual Quote

Schott Extends License to Accelr8's Microarray Slide-Coating Technology

NEW YORK (GenomeWeb News) — Accelr8 today said it has extended a
licensing agreement with Schott  Nexterion that allows Schott to use its surface-coating chemistry to make and market microarray slides.
 
Under the new two-year agreement, Schott will have access to a version of Accelr8’s OptiChem product to produce its Slide HS microarraying slides.
 
The OptiChem technology uses a protein to create an even and stable slide surface, according to Accelr8.
 
Financial terms of the agreement were not released.
 
The two companies previously extended a 2004 agreement for another version of OptiChem.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.